Pharmaceutical Executive
Groundbreaking treatment approaches call for innovative commercialization strategies.
Martin Lachs
Advertisement
Articles by Martin Lachs
Advertisement
Latest Updated Articles
Access and Reimbursement for Adoptive T-Cell Transfer DrugsDecember 11th 2017
Advertisement
Advertisement
Trending on PharmExec
1
Viatris Acquires Pacira BioSciences for $1.65 Billion
2
Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
3
Before You Sign with a New Hub Vendor, Ask These Four Questions
4
ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care
5